Radiolabeled BC8 (Anti-CD45) Antibody Combined With Cyclophosphamide and Total Body Irradiation Followed by HLA-matched Related or Unrelated Stem Cell Transplantation as Treatment for Advanced Acute Lymphocytic Leukemia
Latest Information Update: 08 Apr 2022
At a glance
- Drugs I-131-Apamistamab (Primary) ; Cyclophosphamide
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 07 Jul 2009 Actual end date (Nov 2001) added as reported by ClinicalTrials.gov.
- 07 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Oct 2005 New trial record.